| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |